SD

Sanjay Dhir

Active Director Director DIN 02452461
DIN 02452461 First appointment Jan 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2009
Shareholding value •••• Premium profile

About Sanjay Dhir

Data last updated:

Sanjay Dhir is a Director at Preet Remedies Limited (since 2009), Whole-Time Director at Zenlabs Ethica Limited (since 2016) and Director at Quixotic Pharma Private Limited (since 2018), and holds 1 more current directorship. The companies operate in Pharma and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹152 Cr; the largest is Preet Remedies Limited at ₹62.83 Cr (FY 2025). Earlier, Sanjay Dhir was a Director at Zen Labs India Private Limited (from 2009) and Additional Director at Hexford Laboratories Private Limited (from 2009).

DIN 02452461
Primary Designation Director
Industry Pharma
First Appointment 27 Jan 2009
Oldest Company Age 33 yrs
Largest company Preet Remedies Limited · ₹62.83 Cr (FY 2025)
Combined revenue ₹152 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Preet Remedies Limited U24230CH2005PLC027954
Director01 May 20092005₹62.83 Cr (FY 2025)Active
Zenlabs Ethica Limited L74900CH1993PLC033112
Whole-Time Director11 Aug 20161993₹51.47 Cr (FY 2025)Active
Quixotic Pharma Private Limited U24232PB2002PTC025609
Director01 Feb 20182002₹27.58 Cr (FY 2025)Active
Managing Director15 Jan 20152007₹10.36 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zen Labs India Private Limited U24232CH2009PTC031494
Director27 Jan 20092009Strike Off
Hexford Laboratories Private Limited U24232DL2009PTC195575
Additional Director21 Nov 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oasis Pharma And Phytomolecules Private Limited
Preet Remedies Limited
Zen Labs India Private Limited
Hexford Laboratories Private Limited
Premium access

Shareholding and investment profile for Sanjay Dhir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Dhir

Sanjay Dhir currently holds 4 directorships: Preet Remedies Limited (Director, since 01 May 2009, revenue ₹62.83 Cr (FY 2025)); Zenlabs Ethica Limited (Whole-Time Director, since 11 Aug 2016, revenue ₹51.47 Cr (FY 2025)); Quixotic Pharma Private Limited (Director, since 01 Feb 2018, revenue ₹27.58 Cr (FY 2025)); Oasis Pharma And Phytomolecules Private Limited (Managing Director, since 15 Jan 2015, revenue ₹10.36 Cr (FY 2025)).

Sanjay Dhir was first appointed on 27 Jan 2009 as Director at Zen Labs India Private Limited. The most recent appointment on record is 01 Feb 2018 at Quixotic Pharma Private Limited.

The 4 current companies of Sanjay Dhir that report revenue have a combined latest revenue of ₹152 Cr: Preet Remedies Limited ₹62.83 Cr (FY 2025); Zenlabs Ethica Limited ₹51.47 Cr (FY 2025); Quixotic Pharma Private Limited ₹27.58 Cr (FY 2025); Oasis Pharma And Phytomolecules Private Limited ₹10.36 Cr (FY 2025).

Sanjay Dhir held 2 earlier board appointments: Zen Labs India Private Limited (Director, from 27 Jan 2009); Hexford Laboratories Private Limited (Additional Director, from 21 Nov 2009).

The current boards of Sanjay Dhir's companies include Abhishek Rana (Preet Remedies Limited), Hitesh Popatlal Oswal (Preet Remedies Limited), Prasanna Kumar Rout (Preet Remedies Limited), Sanjeev Kumar (Preet Remedies Limited), Vijendra Kumar Gupta (Preet Remedies Limited), Anurag Malhotra (Zenlabs Ethica Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available